{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:59:16Z","timestamp":1792007956065,"version":"4.4.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bpobgyn.2024.102550","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T23:56:20Z","timestamp":1725407780000},"page":"102550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Hormonal methods for emergency contraception"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7957-7798","authenticated-orcid":false,"given":"Raymond Hang Wun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue Seen Tsing","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon Tracey","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102550_bib1","article-title":"Interventions for emergency contraception","volume":"1","author":"Shen","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2024.102550_bib2","first-page":"53","article-title":"Post coital contraception: a pilot study","volume":"13","author":"Yuzpe","year":"1974","journal-title":"J Reprod Med"},{"key":"10.1016\/j.bpobgyn.2024.102550_bib3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/oxfordjournals.humrep.a138057","article-title":"A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraception","volume":"8","author":"Ho","year":"1993","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2024.102550_bib4","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(98)05145-9","article-title":"Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"9348","key":"10.1016\/j.bpobgyn.2024.102550_bib5","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0140-6736(02)11767-3","article-title":"WHO Research Group on Post-ovulatory Methods of Fertility Regulation. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial","volume":"360","author":"von Hertzen","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2024.102550_bib6","series-title":"FSRH guideline: emergency contraception. Faculty of sexual and reproductive healthcare: london","year":"2017"},{"key":"10.1016\/j.bpobgyn.2024.102550_bib7","series-title":"Selected practice recommendations for contraceptive use","year":"2016"},{"issue":"5","key":"10.1016\/j.bpobgyn.2024.102550_bib8","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/01.AOG.0000239440.02284.45","article-title":"Progesterone receptor modulator for emergency contraception: a randomized controlled trial","volume":"108","author":"Creinin","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"9714","key":"10.1016\/j.bpobgyn.2024.102550_bib9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0140-6736(10)60101-8","article-title":"Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis","volume":"375","author":"Glasier","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2024.102550_bib10","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJM199210083271501","article-title":"Mifepristone (RU486) compared with high-dose estrogen and progestogen for emergency postcoital contraception","volume":"327","author":"Glasier","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpobgyn.2024.102550_bib11","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/bmj.305.6859.927","article-title":"Comparison of Yuzpe regimen, danazol, and mifepristone (RU486) in oral postcoital contraception","volume":"305","author":"Webb","year":"1992","journal-title":"Br Med J"},{"issue":"9154","key":"10.1016\/j.bpobgyn.2024.102550_bib12","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(98)07190-6","article-title":"Comparison of three single doses of mifepristone as emergency contraception: a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2024.102550_bib13","unstructured":"Emergency contraception in the world [Internet]. European consortium for Emergency Contraception; [updated 12 April 2024; cited 5 June 2024]. Available from: https:\/\/www.ec-ec.org\/emergency-contraception-in-the-world\/."},{"key":"10.1016\/j.bpobgyn.2024.102550_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0010-7824(01)00186-X","article-title":"The effects of peri-ovulatory administration of levonorgestrel on the menstrual cycle","volume":"63","author":"Hapangama","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2024.102550_bib15","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1093\/humrep\/deq157","article-title":"Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture","volume":"25","author":"Brache","year":"2010","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.bpobgyn.2024.102550_bib16","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0010-7824(02)00408-0","article-title":"The effects of levonorgestrel on various sperm functions","volume":"66","author":"Yeung","year":"2002","journal-title":"Contraception"},{"issue":"11","key":"10.1016\/j.bpobgyn.2024.102550_bib17","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1093\/humrep\/dem297","article-title":"Mifepristone, but not levonorgestrel, inhibits human blastocyst attachment to an in vitro endometrial three-dimensional cell culture model","volume":"22","author":"Lalitkumar","year":"2007","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102550_bib18","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.fertnstert.2007.11.007","article-title":"Effect of levonorgestrel and mifepristone on endometrial receptivity markers in a three-dimensional human endometrial cell culture model","volume":"91","author":"Meng","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2024.102550_bib19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1477-7827-10-8","article-title":"In vitro assessment of some sperm function following exposure to levonorgestrel in human fallopian tubes","volume":"10","author":"Hermanny","year":"2012","journal-title":"Reprod Biol Endocrinol"},{"issue":"10","key":"10.1016\/j.bpobgyn.2024.102550_bib20","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1093\/humrep\/den260","article-title":"Regulation of muscular contractions in the human Fallopian tube through prostaglandins and progestagens","volume":"23","author":"W\u00e5nggren","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2024.102550_bib21","series-title":"Paper presented at: 47th annual meeting of the society for the study of reproduction","article-title":"Mifepristone, but not levonorgestrel, has suppressive effect on tubal function at pharmacological dose which may contribute to emergency contraceptive action","author":"Li","year":"2014"},{"issue":"6","key":"10.1016\/j.bpobgyn.2024.102550_bib22","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.2047-2927.2014.00261.x","article-title":"An in vitro study of the effect of mifepristone and ulipristal acetate on human sperm functions","volume":"2","author":"Ko","year":"2014","journal-title":"Andrology"},{"issue":"10","key":"10.1016\/j.bpobgyn.2024.102550_bib23","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1093\/humrep\/deu210","article-title":"Ulipristal acetate resembles mifepristone in modulating human fallopian tube function","volume":"29","author":"Li","year":"2014","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.bpobgyn.2024.102550_bib24","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.contraception.2019.07.140","article-title":"Does ulipristal acetate emergency contraception (ella) interfere with implantation?","volume":"100","author":"Li","year":"2019","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2024.102550_bib25","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/humrep\/dev030","article-title":"Effects of ulipristal acetate on human embryo attachment and endometrial cell gene expression in an in vitro co-culture system","volume":"30","author":"Berger","year":"2015","journal-title":"Hum Reprod"},{"issue":"12","key":"10.1016\/j.bpobgyn.2024.102550_bib26","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/humrep\/dex328","article-title":"Effect of ulipristal acetate and mifepristone at emergency contraception dose on the embryo- endometrial attachment using an in vitro human trophoblastic spheroid and endometrial cell co-culture model","volume":"32","author":"Li","year":"2017","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.bpobgyn.2024.102550_bib27","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.contraception.2006.08.015","article-title":"Effectiveness of levonorgestrel emergency contraception given before or after ovulation--a pilot study","volume":"75","author":"Novikova","year":"2007","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.bpobgyn.2024.102550_bib28","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.contraception.2009.12.015","article-title":"Contraceptive efficacy of emergency contraception with levonorgestrel given before or after ovulation","volume":"81","author":"No\u00e9","year":"2010","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.bpobgyn.2024.102550_bib29","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/humrep\/dew055","article-title":"Efficacy of ulipristal acetate for emergency contraception and its effect on the subsequent bleeding pattern when administered before or after ovulation","volume":"31","author":"Li","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2024.102550_bib30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.contraception.2016.03.009","article-title":"Effects of low doses of mifepristone on human embryo implantation process in a three-dimensional human endometrial in vitro co-culture system","volume":"94","author":"Boggavarapu","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2024.102550_bib31","series-title":"Emergency contraceptive pills: medical and service delivery guidance","year":"2018"},{"issue":"12","key":"10.1016\/j.bpobgyn.2024.102550_bib32","first-page":"2785","article-title":"A prospective, randomized, pharmacodynamic study of quick-starting a desogestrel progestin-only pill following ulipristal acetate for emergency contraception","volume":"30","author":"Brache","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2024.102550_bib33","series-title":"Medical eligibility criteria for contraceptive use","year":"2015"},{"issue":"5","key":"10.1016\/j.bpobgyn.2024.102550_bib34","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3109\/00016341003721037","article-title":"Medical abortion in lactating women--low levels of mifepristone in breast milk","volume":"89","author":"Saav","year":"2010","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.bpobgyn.2024.102550_bib35","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1093\/humrep\/dep076","article-title":"Pregnancy outcome after levonorgestrel-only emergency contraception failure: a prospective cohort study","volume":"24","author":"Zhang","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2024.102550_bib36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1095\/biolreprod.113.117226","article-title":"Physical and mental development of children after levonorgestrel emergency contraception exposure: a follow-up prospective cohort study","volume":"91","author":"Zhang","year":"2014","journal-title":"Biol Reprod"},{"issue":"2","key":"10.1016\/j.bpobgyn.2024.102550_bib37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.contraception.2015.11.001","article-title":"Safety data for levonorgestrel, ulipristal acetate and Yuzpe regimens for emergency contraception","volume":"93","author":"Jatlaoui","year":"2016","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.bpobgyn.2024.102550_bib38","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/humrep\/deaa024","article-title":"Ulipristal acetate and pregnancy outcome-an observational study","volume":"35","author":"Wagner","year":"2020","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.bpobgyn.2024.102550_bib39","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/1471-0528.12147","article-title":"Continuation of pregnancy after first-trimester exposure to mifepristone: an observational prospective study","volume":"120","author":"Bernard","year":"2013","journal-title":"BJOG"},{"issue":"4","key":"10.1016\/j.bpobgyn.2024.102550_bib40","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.contraception.2011.02.009","article-title":"Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel","volume":"84","author":"Glasier","year":"2011","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.bpobgyn.2024.102550_bib41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.contraception.2014.11.001","article-title":"Effect of body weight and BMI on the efficacy of levonorgestrel emergency contraception","volume":"91","author":"Kapp","year":"2015","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.bpobgyn.2024.102550_bib42","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.contraception.2017.01.004","article-title":"Pharmacokinetics of levonorgestrel and ulipristal acetate emergency contraception in women with normal and obese body mass index","volume":"95","author":"Praditpan","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2024.102550_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2024.110474","article-title":"Emergency contraception for individuals weighing 80 kg or greater: a randomized trial of 30 mg ulipristal acetate and 1.5 mg or 3.0 mg levonorgestrel","author":"Edelman","year":"2024","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.bpobgyn.2024.102550_bib45","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.contraception.2015.12.015","article-title":"A prospective, open-label, multicenter study to assess the pharmacodynamics and safety of repeated use of 30 mg ulipristal acetate","volume":"93","author":"Jesam","year":"2016","journal-title":"Contraception"},{"issue":"10262","key":"10.1016\/j.bpobgyn.2024.102550_bib46","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/S0140-6736(20)31785-2","article-title":"Use of effective contraception following provision of the progestogen-only pill for women presenting to community pharmacies for emergency contraception (Bridge-It): a pragmatic cluster-randomised crossover trial","volume":"396","author":"Cameron","year":"2020","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.bpobgyn.2024.102550_bib47","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1093\/humrep\/dev115","article-title":"The effects on ovarian activity of ulipristal acetate when 'quickstarting' a combined oral contraceptive pill: a prospective, randomized, double-blind parallel-arm, placebo-controlled study","volume":"30","author":"Cameron","year":"2015","journal-title":"Hum Reprod"},{"issue":"7511","key":"10.1016\/j.bpobgyn.2024.102550_bib48","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/bmj.38519.440266.8F","article-title":"Impact on contraceptive practice of making emergency hormonal contraception available over the counter in Great Britain: repeated cross sectional surveys","volume":"331","author":"Marston","year":"2005","journal-title":"Br Med J"},{"issue":"6","key":"10.1016\/j.bpobgyn.2024.102550_bib49","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.contraception.2006.01.012","article-title":"The impact of pharmacy access to emergency contraceptive pills in France","volume":"73","author":"Moreau","year":"2006","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.bpobgyn.2024.102550_bib50","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.annemergmed.2005.07.001","article-title":"Nonprescription availability of emergency contraception in the United States","volume":"47","author":"Ranney","year":"2006","journal-title":"Ann Emerg Med"},{"issue":"10","key":"10.1016\/j.bpobgyn.2024.102550_bib51","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1093\/humrep\/deh425","article-title":"Effect of advanced provision of emergency contraception on women's contraceptive behaviour: a randomized controlled trial","volume":"19","author":"Lo","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2024.102550_bib52","first-page":"CD005497","article-title":"Advance provision of emergency contraception for pregnancy prevention","volume":"2","author":"Polis","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.bpobgyn.2024.102550_bib53","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.contraception.2012.09.011","article-title":"Advance supply of emergency contraception: a systematic review","volume":"87","author":"Rodriguez","year":"2013","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102550_bib54","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/01.AOG.0000250904.06923.4a","article-title":"Population effect of increased access to emergency contraceptive pills: a systematic review","volume":"109","author":"Raymond","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2024.102550_bib55","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/0897190014544795","article-title":"Preferential cyclooxygenase 2 inhibitors as a nonhormonal method of emergency contraception: a look at the evidence","volume":"29","author":"Weiss","year":"2016","journal-title":"J Pharm Pract"},{"issue":"10405","key":"10.1016\/j.bpobgyn.2024.102550_bib56","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0140-6736(23)01240-0","article-title":"Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial","volume":"402","author":"Li","year":"2023","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.bpobgyn.2024.102550_bib57","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa2022141","article-title":"Levonorgestrel vs copper intrauterine devices for emergency contraception","volume":"384","author":"Turok","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.bpobgyn.2024.102550_bib58","article-title":"Progestin intrauterine devices versus copper intrauterine devices for emergency contraception","volume":"2","author":"Ramanadhan","year":"2023","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693424001044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693424001044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T19:21:28Z","timestamp":1733253688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693424001044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":57,"alternative-id":["S1521693424001044"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2024.102550","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hormonal methods for emergency contraception","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2024.102550","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102550"}}